Oral Wegovy Captures One-Third of Prescriptions as Adoption Accelerates
Novo Nordisk's oral Wegovy treatment has captured approximately one-third of all Wegovy prescriptions by May, according to a Bank of America report. The tablet formulation is gaining traction quickly since its January launch and now accounts for about 40% of new prescriptions weekly.
Tickers: $NVO